NCT00465621View on ClinicalTrials.gov

Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2007

Conditions

Open-Angle GlaucomaOcular Hypertension

Interventions

DRUG

Xalatan

Trial Locations (1)

30342

Atlanta, Atlanta

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY